Literature DB >> 26239706

Controversies in venous thromboembolism--2015.

David Keeling1, Frederikus A Klok2, Grégoire Le Gal3.   

Abstract

Venous thromboembolism is commonly encountered both in the community and the in-patient setting. Despite major advances in diagnosis and treatment, there remain challenges in several clinical areas as a result of insufficient evidence to guide practice. This review covers six controversial topics, summarizes the best available evidence, and presents recommendations for practice. The clinical relevance of calf vein thrombosis and sub-segmental pulmonary embolism are often questioned; this has implications for both their diagnosis and management. The role of thrombolysis for the treatment of deep vein thrombosis (DVT) is discussed in consideration of the potential benefits and risks. Residual vein obstruction has been proposed as a predictor of recurrent thrombosis; we consider its relevance when determining the duration of anticoagulant treatment. The post-thrombotic syndrome (PTS) can be a disabling and costly consequence of DVT with limited options for prevention and treatment. We review the available evidence related to compression stockings for PTS prevention. Finally, the relationship between cancer and VTE is well recognized and this review considers the value of screening for occult cancer in patients with unprovoked VTE.

Entities:  

Keywords:  Cancer screening; Compression stockings; Deep vein thrombosis; Diagnosis; Post-thrombotic syndrome; Pulmonary embolism; Residual vein obstruction; Subsegmental pulmonary embolism; Thrombolysis; Venous thromboembolism

Mesh:

Substances:

Year:  2015        PMID: 26239706     DOI: 10.1016/j.blre.2015.07.003

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  3 in total

1.  Functional cyclophilin D moderates platelet adhesion, but enhances the lytic resistance of fibrin.

Authors:  Imre Varjú; Veronika Judit Farkas; László Kőhidai; László Szabó; Ádám Zoltán Farkas; Lívia Polgár; Christos Chinopoulos; Krasimir Kolev
Journal:  Sci Rep       Date:  2018-03-29       Impact factor: 4.379

2.  Cancer Screening in Patients with Unprovoked Thromboembolism: How to do it and Who Benefits?

Authors:  Filipa Ferreira; José Pereira; Ana Lynce; José Nunes Marques; Ana Martins
Journal:  Cureus       Date:  2020-02-10

3.  Impact of Pregnancy-Related Venous Thromboembolism on Quality of Patients' Lives.

Authors:  Naser Al-Husban; Leena N Alnsour; Zaid El-Adwan; Nada A Saleh; Mazen El-Zibdeh
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.